How to Transition a Teen With Hemophilia to Adult Care
At a Glance
Transitioning hemophilia care to adulthood should begin in early adolescence and progress over several years. The safest plan builds treatment and refill skills, prepares for emergencies, addresses privacy and insurance, and includes a planned hand-off to an adult Hemophilia Treatment Center.
In this answer
3 sections
Transitioning a pediatric hemophilia patient to adult care is a gradual, developmental process that extends from early adolescence into young adulthood [1]. Rather than a single transfer visit right before college, a safe transition requires years of continuous education, building self-management skills, and a structured “warm hand-off” between the pediatric and adult Hemophilia Treatment Center (HTC) teams [2][3].
A Gradual Timeline for Independence
Becoming independent in hemophilia care happens in stages. Readiness varies greatly depending on treatment type, physical dexterity, and individual maturity. While research shows that readiness generally increases throughout the teenage years, full self-management is often not achieved until the early twenties [4][5].
Instead of focusing on strict age requirements, focus on demonstrated competencies. Approximate milestones seen in research include:
- Early to Mid-Teens: Adolescents often begin learning self-infusion or treatment administration around age 12 [5]. Readiness to transition starts to build during this time [4].
- Late Teens (College Age): By age 17, many teens can perform their treatments independently [5]. However, they may still need parental support for complex tasks like insurance management and reordering supplies [6].
- Early Twenties: More complex skills, such as independent bleeding management and direct communication with the hemophilia physician, typically mature around ages 19 to 22 [5][7].
Building Core Self-Management Skills
To prepare for college, your teenager needs to master several practical competencies beyond simply taking their medication.
Treatment Administration and Tracking
Core self-management involves learning to independently administer treatments, whether that is traditional clotting factor or non-factor therapies (medications that mimic or enhance the blood’s ability to clot without replacing the missing factor directly) [5]. Because treatments have highly specific monitoring requirements, education must be tailored to the exact therapy your teen is using [8]. Using digital apps or physical logs to track product use, record infusions, and document bleeding events supports adherence and independence [9].
Managing Logistics, Insurance, and Privacy
Access to medication can be a significant barrier during transition. Young adults frequently report challenges managing their medication stock and navigating insurance changes [2][6]. Before leaving for college, teens should practice checking their inventory, understanding how to order refills to a dorm or apartment, managing safe storage (like a dedicated mini-fridge for medication), and learning the basics of their health insurance coverage [10][4].
Additionally, when your teen turns 18, privacy laws change. A parent can no longer automatically discuss care or obtain records. Discuss signing an information-sharing authorization or health-care proxy so you can remain involved as a safety net [11].
Emergency Preparedness and Red Flags
Your teen must know the difference between routine prophylaxis (preventative treatment taken regularly to prevent bleeds) and their breakthrough-bleed plan (how to treat an active, unexpected bleed) [12].
It is critical to follow an individualized HTC plan for acute bleeding. While factor replacement is used for many patients [13], those using non-factor therapies (like emicizumab) or those with an inhibitor (antibodies that stop standard factor from working) require highly specific emergency treatments. Some standard treatments can cause severe complications if combined with non-factor therapies [14][12].
Your teen should carry a detailed, updated emergency letter stating their diagnosis, inhibitor status, prescribed emergency product, exact dose, treatments to avoid, and HTC contact info.
Teach your teen to recognize urgent red flags that require immediate action, including:
- Suspected head, neck, or throat bleeding (or any major head injury)
- Severe headaches or sudden neurologic changes
- Chest, abdominal, flank, or hip pain [15]
- Rapidly enlarging muscle or joint bleeds
If these occur, they should follow their plan to treat promptly, contact the HTC immediately, and seek emergency services. They should not wait for an emergency department evaluation before administering their prescribed emergency treatment if their plan instructs them to treat first [16].
Coordinating the “Warm Hand-Off”
A successful transfer of care involves planned, structured collaboration between the pediatric and adult care teams [3].
- Structured Medical Summaries: Your pediatric team should provide a structured medical summary (a comprehensive document detailing their medical history) and treatment plan to the receiving adult physician [17][18]. This ensures that all clinical details are clearly communicated.
- Introductory Appointments: Research suggests that meeting the adult care team before the official transfer is associated with better attendance at future appointments and improved ownership of care [4][19]. Schedule this visit before the chaotic college move-in period.
- Emergency Care Networks: Because your teen will be living in a new location, it is important to identify local emergency departments. Confirm in advance how the HTC will coordinate with the local emergency department and ensure the required product will be available, rather than assuming local doctors will already know how to manage hemophilia [16][20].
Common questions in this guide
When should preparation for adult hemophilia care begin?
What skills should my teen have before moving to adult hemophilia care?
What belongs in a hemophilia emergency letter?
How does a warm hand-off to an adult hemophilia treatment center work?
What should a young adult with hemophilia do after a head injury or sudden severe pain?
How can parents help after their teen turns 18?
How should a family prepare hemophilia care for college?
Related questions
Show more
Get notified when new evidence is published on Hemophilia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experience.
Bidlingmaier C, Olivieri M, Schilling FH, et al.
Hamostaseologie 2020; (40(1)):97-104 doi:10.1055/s-0039-3402804.
PMID: 31994160 - 2
Challenges in Hemophilia Care and Requirements for Pediatric-to-Adult Transition: Single-Center Experience from a Resource-Limited Setting.
Sirachainan N, Kempka K, Tiengtrakulthong A, et al.
Patient preference and adherence 2026; (20()):633744 doi:10.2147/PPA.S633744.
PMID: 42787772 - 3
Multidisciplinary Team Care of Patients with Hemophilic Arthropathy: A Qualitative Assessment of Contemporary Practice in the UK and Canada : Canada/UK: MDT Practices for Hemophilia.
St-Louis J, Chowdary P, Dolan G, et al.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2022; (28()):10760296211070002 doi:10.1177/10760296211070002.
PMID: 35060765 - 4
Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study.
Brands MR, Janssen EAM, Cnossen MH, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2023; (29(5)):1191-1201 doi:10.1111/hae.14834.
PMID: 37602825 - 5
Achieving self-management of prophylactic treatment in adolescents: The case of haemophilia.
Schrijvers L, Beijlevelt-Van der Zande M, Peters M, et al.
Patient education and counseling 2016; (99(7)):1179-1183 doi:10.1016/j.pec.2016.01.016.
PMID: 26851159 - 6
Adherence to prophylactic treatment in adult patients with severe hemophilia in Poland.
Zdziarska J, Górska-Kosicka M, Jamrozik M, et al.
Polish archives of internal medicine 2022; (132(7-8)) doi:10.20452/pamw.16280.
PMID: 35925049 - 7
Promoting self-management and adherence during prophylaxis: evidence-based recommendations for haemophilia professionals.
Schrijvers LH, Schuurmans MJ, Fischer K
Haemophilia : the official journal of the World Federation of Hemophilia 2016; (22(4)):499-506 doi:10.1111/hae.12904.
PMID: 27075653 - 8
Transforming Hemophilia Treatment With Novel Rebalancing Agents: Clinical Studies and Practical Perspectives.
Chou SC, Weng TF, Chen YC
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2026; (32()):10760296261480921 doi:10.1177/10760296261480921.
PMID: 42689416 - 9
Telehealth Interventions for Improving Self-Management in Patients With Hemophilia: Scoping Review of Clinical Studies.
Qian W, Lam TT, Lam HHW, et al.
Journal of medical Internet research 2019; (21(7)):e12340 doi:10.2196/12340.
PMID: 31293241 - 10
Unmet needs in the transition to adulthood: 18- to 30-year-old people with hemophilia.
Quon D, Reding M, Guelcher C, et al.
American journal of hematology 2015; (90 Suppl 2()):S17-22 doi:10.1002/ajh.24219.
PMID: 26619193 - 11
Motivational techniques to improve self-care in hemophilia: the need to support autonomy in children.
Bérubé S, Mouillard F, Amesse C, Sultan S
BMC pediatrics 2016; (16()):4 doi:10.1186/s12887-016-0542-9.
PMID: 26754457 - 12
Personalized Treatment of Hemophilia: Matching Therapies to Patient Needs in a Rapidly Evolving Landscape.
Szanto T, Lassila R
Drugs 2026; (86(11)):1781-1794 doi:10.1007/s40265-026-02386-y.
PMID: 42786360 - 13
Clinical Scenarios in Hospitalized Patients With Hemophilia.
Alvarez-Payares JC, Ariza Parra EJ, Trejos Tenorio AMM, et al.
Cureus 2026; (18(4)):e106284 doi:10.7759/cureus.106284.
PMID: 42078236 - 14
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.
Sidonio RF, Young G, Escuriola Ettingshausen C, et al.
Research and practice in thrombosis and haemostasis 2025; (9(4)):102926 doi:10.1016/j.rpth.2025.102926.
PMID: 40808796 - 15
Splenic artery embolization for the treatment of spontaneous splenic rupture in hemophilia A: a case report.
He X, Zhang J
AME case reports 2025; (9()):113 doi:10.21037/acr-2025-141.
PMID: 41210426 - 16
Invisible bleeds: Lived experiences and barriers to care for men with hemophilia.
Arya S, Siad FM, Wilton P, et al.
Journal of thrombosis and haemostasis : JTH 2022; (20(2)):296-306 doi:10.1111/jth.15570.
PMID: 34689399 - 17
Health care transition from pediatric to adult care: an evidence-based guideline.
Pape L, Ernst G
European journal of pediatrics 2022; (181(5)):1951-1958 doi:10.1007/s00431-022-04385-z.
PMID: 35084548 - 18
Core components of a specialty-wide model of care for transition to adult healthcare services: a systematic review of guidelines.
Deakin CT, Brothers L, Young S, et al.
International journal of adolescent medicine and health 2026; doi:10.1515/ijamh-2026-0101.
PMID: 42762068 - 19
A longitudinal, observational study of the features of transitional healthcare associated with better outcomes for young people with long-term conditions.
Colver A, McConachie H, Le Couteur A, et al.
BMC medicine 2018; (16(1)):111 doi:10.1186/s12916-018-1102-y.
PMID: 30032726 - 20
A Web Site to Improve Management of Patients with Inherited Bleeding Disorders in the Emergency Department: Results at 2 Years.
Tagliaferri A, Di Perna C, Biasoli C, et al.
Seminars in thrombosis and hemostasis 2016; (42(5)):589-98 doi:10.1055/s-0036-1571312.
PMID: 27071049
This page is for informational purposes only and does not constitute medical advice about a young person’s hemophilia care. Work with the pediatric and adult hemophilia treatment center teams to create an individualized transition and emergency plan.